CUV 1.82% $15.69 clinuvel pharmaceuticals limited

open briefing - epitan chairman & cfo on strategy , page-4

  1. 4,756 Posts.
    I'd have to agree with you stainless, with all the trial results released to date indicating nothing but positives it would seem that FDA approval is but a matter of when the announcement from the US is made.

    The potential of Epitans product is huge.

    JMHO

    Cheers,

    Fig Jam
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.69
Change
0.280(1.82%)
Mkt cap ! $785.7M
Open High Low Value Volume
$15.16 $15.98 $15.03 $2.391M 152.0K

Buyers (Bids)

No. Vol. Price($)
1 1355 $15.64
 

Sellers (Offers)

Price($) Vol. No.
$15.75 1783 3
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.